Granahan Investment Management LLC, an investment adviser based in Massachusetts, has filed an amendment with the Securities and Exchange Commission (SEC) indicating that it no longer holds any beneficial ownership in bluebird bio, Inc. The filing, specifically a Schedule 13G/A, was made pursuant to Rule 13d-1(b), which is used by certain qualified institutional investors to report holdings in a company. The document, dated September 30, 2024, shows that Granahan Investment Management LLC has zero shares with no voting or dispositive power in the common stock of bluebird bio, representing 0.00% of the class. This indicates that the firm has ceased to be a beneficial owner of more than five percent of bluebird bio's securities. The filing was certified by Brian Granahan, Chief Compliance Officer of Granahan Investment Management LLC, on November 14, 2024.

Granahan Investment Management LLC, an investment adviser based in Massachusetts, has filed an amendment with the Securities and Exchange Commission (SEC) indicating that it no longer holds any beneficial ownership in bluebird bio, Inc. The filing, specifically a Schedule 13G/A, was made pursuant to Rule 13d-1(b), which is used by certain qualified institutional investors to report holdings in a company. The document, dated September 30, 2024, shows that Granahan Investment Management LLC has zero shares with no voting or dispositive power in the common stock of bluebird bio, representing 0.00% of the class. This indicates that the firm has ceased to be a beneficial owner of more than five percent of bluebird bio's securities. The filing was certified by Brian Granahan, Chief Compliance Officer of Granahan Investment Management LLC, on November 14, 2024.